"The Latest Breakthrough in Understanding Diabetes Was Made By an Algorithm"
A recent study, published in the journal Science Translational Medicine, demonstrates the broader promise of precision medicine beyond genome sequencing—and in understanding an extremely common disease: Type 2 Diabetes. "This is the first tangible demonstration of precision medicine that could be applied to a more common, complex disease," says study author Joel Dudley, PhD, director of biomedical informatics at the Icahn School of Medicine at Mount Sinai. Learn more.
Press Release
Mount Sinai and Hasso Plattner Institute Launch New Institute for Digital Health
Mar 29, 2019 View All Press Releases